Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia

Rituximab-combined therapeutic regimens have been recommended for treatment of Waldenström's Macroglobulinemia (WM). We report one WM patient who developed interstitial pneumonitis after rituximab therapy.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Case Rep
Asıl Yazarlar: Bai, Xueyan, Cui, Qu, Liu, Yuanbo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BlackWell Publishing Ltd 2015
Konular:
Letter to the Editor
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352371/
https://ncbi.nlm.nih.gov/pubmed/25798285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.152
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller